Silexion Therapeutics Corp cotiza a 0.18 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $154000 con un margen de flujo de caja libre del -6985.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that h…
| Periodo | 2026-05 | 2025-11 | 2025-08 | 2025-03 |
|---|---|---|---|---|
| Real | $-8.50 | $-28.80 | — | $-3114.00 |
| Estimado | $-12.90 | $-34.00 | $-0.21 | $-147.00 |
| Sorpresa | +34.1% | +15.3% | — | -2018.4% |
| Métrica | SLXN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -7504.5% | -38.6% | -7465.9% |
| Net Margin | -7685.2% | -33.6% | -7651.6% |
| FCF Margin | -6985.8% | -13.9% | -6972.0% |
| ROE | -457.6% | -40.4% | -417.2% |
| ROA | -165.1% | -32.0% | -133.1% |
| Current Ratio | 2.41 | 2.84 | -0.43 |
| Debt / Equity | — | 0.28 | — |